Trial intelligence / Profile preview

LUCIDATE: Ranibizumab vs Laser in Diabetic Macular Oedema

NCT01223612Phase 4Completed

Sponsor
Moorfields Eye Hospital
Start
Oct 2010
Primary completion
Jul 2012
Modality
Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of ranibizumab in diabetic macular edema (DME), sponsored by Moorfields Eye Hospital. Started Oct 2010; status: completed.

02

Drugs

ranibizumab
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT01223612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01223612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call